Point72 Middle East FZE’s Abbott ABT Stock Holding History

Point72 Middle East FZE’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-239,160	Closed	-$23.9M	–	1453
2023 Q3	$23.2M	Buy	+239,160	New	+$25.1M	0.76%	16
2023 Q2	–	Sell	-177,730	Closed	-$18.9M	–	1488
2023 Q1	$18M	Buy	+177,730	New	+$18.8M	0.61%	19

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Point72 Middle East FZE's ABT Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Abbott (ABT) in Q4 2023, closing a stake of 239,160 shares — an estimated $23.9M sold.

Point72 Middle East FZE first reported a position in ABT in Q1 2023 and held it in 2 quarters. The position peaked at $23.2M in Q3 2023. 2,886 funds tracked by Wall St. Rank hold ABT as of Q4 2023.

Point72 Middle East FZE reported no remaining Abbott position as of Q4 2023 after selling out during the quarter.
Point72 Middle East FZE sold 239,160 Abbott shares in Q4 2023, an estimated $23.9M.
Point72 Middle East FZE first reported a position in Abbott in Q1 2023 and held it in 2 quarters.
Point72 Middle East FZE's Abbott position peaked at $23.2M in Q3 2023.
2,886 funds tracked by Wall St. Rank held Abbott as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.